-
Christian Tharp Talks The Biotech Industry And The IBB
Saturday, October 10, 2015 - 12:15pm | 609Read More...Christian Tharp was recently a guest on #PreMarket Prep, a daily trading idea radio show hosted by Joel Elconin and Dennis Dick. The biotech expert and author of “Five-Star Stock Watch” delved into several issues, including his expectations for the broader market, his target for...
-
Merrimack Forms A Major Topping Pattern
Wednesday, June 10, 2015 - 10:36am | 422Read More...The S&P 500 has been declining slowly over the last month. The Nasdaq Composite has as well, and let’s not even discuss the carnage that has been the Dow Jones Transportation Average. Biotechnology has been one of the top industries for quite sometime, and it had been weathering this...
-
Why Intercept Might Be A Better Bet Than Biogen Right Now
Tuesday, March 24, 2015 - 7:43am | 269Read More...Christian Tharp was recently a guest on #PreMarket Prep, a daily trading idea radio show hosted by Joel Elconin and Dennis Dick. Biotech Expert and "Five-Star Stock Watch" Author Christian Tharp commented on biotech stocks last Friday. Tharp noted that Intercept Pharmaceuticals Inc...
-
#PreMarket Prep For The Week Of February 2: Trading Ideas For Equities, Bonds & Currencies
Sunday, February 1, 2015 - 3:00pm | 1259Read More...We’ll cover day trading ideas, bond markets and macro events on this week’s #PreMarket Prep broadcast, sponsored by Marketfy. Be sure to tune in at 8:00 a.m. EST Monday-Friday here to tune in to the exciting show. Monday, February 2, 8:35 a.m. Tim Anderson (@TJAnderson1),...
-
3 Technical Traders Prepare For Amazon's Earnings
Thursday, January 29, 2015 - 4:35pm | 367Read More...Amazon.com, Inc. (NASDAQ: AMZN) reports earnings after the close on Thursday and three technical traders told Benzinga what they think of the stock. CMT Christian Tharp thought that Amazon “has major support at $185 dating back to May of last year,” but that resistance forms...
-
Microsoft Trending Lower Ahead Of Q2 Earnings Report
Monday, January 26, 2015 - 4:01pm | 267Read More...Microsoft Corporation (NASDAQ: MSFT) reports Q2 earnings after the market close on Monday. Analysts expect revenue of $26.33 billion with EPS of $0.71. Nomura analyst Rick Sherlund indicated that there may be some confusion due to restructuring charges and that some revenue may need to be...
-
2 Technical Perspectives On IBM Ahead Of Q4 Earnings
Tuesday, January 20, 2015 - 4:42pm | 242Read More...Two traders gave their perspective on International Business Machines Corp. (NYSE: IBM) ahead of the company’s Q4 earnings release following Tuesday’s close. CMT Christian Tharp told Benzinga that "IBM has been trying to hold $155 since the beginning of 2015. If the...
-
Technical Trading Levels For Netflix
Tuesday, January 20, 2015 - 4:38pm | 130Read More...Heading into the Q4 earnings release for Netflix, Inc. (NASDAQ: NFLX), CMT Christian Tharp told Benzinga his thoughts on its technical levels. "NFLX has a general support in the $315-20 area that dates back to the beginning of 2014," according to Tharp. "Earnings could be...
-
Technical Traders On Facebook's Run To $100
Wednesday, January 14, 2015 - 5:55pm | 250Read More...Oppenheimer raised its price target on Facebook Inc (NASDAQ: FB) Wednesday to $100. Technical traders Chrisitan Tharp and Richard Suttmeier suggested what levels the stock needs to break through to make a sustained move higher. Tharp noted the stock “has been trending sideways for the...
-
#PreMarket Prep Guest List For The Week Of January 5, 2015
Saturday, January 3, 2015 - 3:21pm | 1191Read More...Equity analysts, fund managers and traders in forex, options and equities will all be featured guests on this week’s #PreMarket Prep broadcast, sponsored by Marketfy. Tune in at 8:00 am EST Monday-Friday here. Monday, January 5, 8:20 a.m. Jeffrey Hirsch (@AlmanacTrader), Editor-In-...
-
A Technical Look At Biogen's Huge Rally
Wednesday, December 3, 2014 - 1:14pm | 536Read More...For investors that dabble in biotech stocks, it is common knowledge that these entities react to drug trial results and FDA approvals more so than on earnings announcements and ratings changes. There is no better better example of this occurring than in the price action of Biogen Idec Inc (...
-
12 Money Myths Just Debunked By Experts
Friday, November 14, 2014 - 11:36am | 1599Read More...Wall Street isn't the most transparent place in the world. Day traders, casual investors and even those looking to diversify their retirement portfolios are subject to a number of money myths lurking beneath the market's surface. Benzinga interviewed 12 financial experts to discover...
-
#PreMarket Prep Guest List For The Week Of August 25, 2014
Friday, August 22, 2014 - 4:31pm | 1170Read More...It's a special week on Benzinga’s #PreMarket Prep broadcast, sponsored by OptionsHouse! We're offering a ton of specials on Marketfy investor education products, so be sure to tune in at 8:00 a.m. EST Monday-Friday here to learn how to take advantage of these huge discounts....
